Disorders of Sodium
Endocrinology and Metabolism Clinics of North America · 2026
DOI: 10.1016/j.ecl.2025.02.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2026. Verfasst von Aaron Alindogan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, UTHSCSA, Floyd Curl Drive, MC 7736, San Antonio, TX 78229, USA. Hauptthemen laut MEDLINE: Hyponatremia, Hypernatremia, Inappropriate ADH Syndrome, Sodium. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Sodium imbalances are a common occurrence in the emergency department. Although recognition and diagnosis are relatively straightforward, discovering the cause and management should be approached systematically. The most important history items to ascertain is if the patient has symptoms and how long this imbalance has taken to develop. Treatment rapidity depends on severity of symptoms with the most rapid treatment occurring in only the severely symptomatic. Overcorrection has dire consequences and must be approached in a careful and systematic fashion in order to prevent these devastating consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, UTHSCSA, Floyd Curl Drive, MC 7736, San Antonio, TX 78229, USA.
- Department of Emergency Medicine, UTHSCSA, Floyd Curl Drive, MC 7736, San Antonio, TX 78229, USA. Electronic address: josephr1@uthscsa.edu.
Zitieren
APA
Alindogan, A., & Joseph, R. (2026). Disorders of Sodium. Endocrinology and Metabolism Clinics of North America. https://doi.org/10.1016/j.ecl.2025.02.003
Vancouver
Alindogan A, Joseph R. Disorders of Sodium. Endocrinology and Metabolism Clinics of North America. 2026. doi:10.1016/j.ecl.2025.02.003
BibTeX
@article{Alindogan2026,
author = {Alindogan, Aaron and Joseph, Ryan},
title = {Disorders of Sodium},
journal = {Endocrinology and Metabolism Clinics of North America},
year = {2026},
doi = {10.1016/j.ecl.2025.02.003}
}
EUVIMED